Get it on Google Play

LB Pharmaceuticals presents LB-102 data at ECNP congress

October 10, 2026 8:00 AM EDT Send to a Friend
LB Pharmaceuticals Inc. (Nasdaq: LBRX) presented four posters at the 39th European College of Neuropsychopharmacology (ECNP) Congress in Munich, Germany ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login